HomeADAP • NASDAQ
add
Adaptimmune Therapeutics PLC - ADR
Previous close
$0.64
Day range
$0.60 - $0.66
Year range
$0.42 - $2.05
Market cap
168.30M USD
Avg Volume
1.96M
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 40.90M | 458.83% |
Operating expense | 55.58M | 3.02% |
Net income | -17.62M | 61.37% |
Net profit margin | -43.07 | 93.09% |
Earnings per share | -0.01 | 70.15% |
EBITDA | -11.86M | 72.88% |
Effective tax rate | -4.95% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 186.09M | 15.06% |
Total assets | 317.44M | 7.01% |
Total liabilities | 237.45M | 13.88% |
Total equity | 79.99M | — |
Shares outstanding | 255.88M | — |
Price to book | 2.05 | — |
Return on assets | -11.48% | — |
Return on capital | -24.62% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -17.62M | 61.37% |
Cash from operations | -54.45M | -20.58% |
Cash from investing | -66.02M | -215.20% |
Cash from financing | 25.00M | 4,094.80% |
Net change in cash | -95.25M | -840.01% |
Free cash flow | -44.13M | -74.80% |
About
Founded
2008
Website
Employees
449
